MASSACHUSETTS CAPITAL RESOURCE COMPANY was established in 1977 as a limited partnership privately owned and funded by Massachusetts-based life insurance companies. The Company’s mission was to create a source of risk capital to fill the senior debt to equity funding “gap” experienced by growing companies. Their investment activity complements, rather than competes with, the financing provided by senior lenders and equity investors. Mass. Capital provides higher risk growth and acquisition capital to manufacturing, distribution, service and technology companies. They focus on emerging growth and middle market companies with operations in Massachusetts. Their investments are structured to fit the specific needs of portfolio companies and to complement funding available from senior lenders and equity investors.
RA Capital Management is a Boston-based investment advisor founded in 2004, specializing in the life sciences and healthcare sectors. The firm focuses on early-stage companies developing innovative technologies, products, and services in drug development, medical devices, diagnostics, and research tools. With a team of professionals trained in biology, chemistry, and medicine, RA Capital Management leverages its extensive industry and business development experience to identify and invest in promising healthcare ventures. As a Registered Investment Adviser, the firm employs a strategic approach that includes both venture capital investments and a hedge fund strategy, targeting opportunities primarily in the United States and Europe.
MassVentures meets critical capital needs in the Massachusetts innovation economy, providing seed and early-stage venture funding to high growth startups as they move from concept to commercialization. The Boston-based venture firm was formed in 1978 as a quasi-public corporation by the Legislature of the Commonwealth of Massachusetts, governed by an independent Board of Directors, and managed by experienced venture capitalists. Leveraging the entrepreneurial spirit, educated workforce, and centers of innovation in Massachusetts, MassVentures has a track record of success with early-stage ventures.
The National Science Foundation (NSF) is an independent federal agency established in 1950 and based in Alexandria, Virginia. It is dedicated to supporting research and education in science and engineering across a wide range of disciplines. The NSF provides significant non-dilutive funding, up to $1.5 million, to startups and small businesses through its America's Seed Fund initiative, which is part of the Small Business Innovation Research (SBIR) program mandated by Congress. With an operating budget of approximately $7.8 billion, the NSF is committed to advancing fundamental research and education, thus fostering innovation and technological development in the United States.
MassChallenge is a global nonprofit startup accelerator headquartered in Boston, Massachusetts, founded in 2009. It supports early-stage entrepreneurs from various industries, including technology, healthcare, and finance, by providing mentorship, resources, and networking opportunities. With locations in countries such as Israel, Mexico, Switzerland, and Texas, MassChallenge operates a non-equity model, allowing startups to retain full ownership while benefiting from expert guidance and connections. The accelerator conducts various programs tailored to specific sectors, such as MassChallenge HealthTech and MassChallenge FinTech, which facilitate partnerships between startups and established enterprises to drive innovation and market growth. Through its extensive global network, MassChallenge aims to strengthen the innovation ecosystem and empower high-potential startups to create meaningful impact.
Polaris Partners is a multibillion-dollar investment firm founded in 1996 and headquartered in Boston, Massachusetts, with an additional office in San Francisco. The firm specializes in investing in healthcare and biotechnology companies, focusing on various aspects of the sector. Its healthcare portfolio includes companies that develop innovative care delivery models, such as digital health solutions, consumer-centric services, patient-provider interactions, as well as data science and analytics. In the biotechnology realm, Polaris targets life sciences firms engaged in research and development of therapeutics, genomic technologies, and molecular platforms. With over 20 years of experience, Polaris Partners collaborates with repeat entrepreneurs and innovators, supporting ventures from their inception through to profitable growth.
Atlas Venture is an early-stage venture capital firm based in Cambridge, Massachusetts, founded in 1980. The firm specializes in creating and investing in biotech startup companies, primarily in the life sciences sector, and emphasizes a seed-led venture creation strategy. Atlas Venture focuses on identifying and nurturing promising entrepreneurs to build scalable businesses that can deliver significant value. The firm has a history of successful investments, with a portfolio that includes over 350 companies across various countries, resulting in numerous acquisitions and public offerings. Atlas Venture typically invests between $500,000 and $5 million in its early-stage ventures, and its investment team consists of experienced operating executives and venture capitalists. The firm has established separate teams dedicated to life sciences and technology, with the life sciences group retaining the Atlas name.
General Catalyst is a venture capital firm established in 2000 and based in San Francisco, California. The firm specializes in early-stage and growth equity investments across various sectors, including consumer, enterprise, fintech, cryptocurrency, and health assurance. By fostering an environment conducive to growth, General Catalyst aims to accelerate the development of innovative ideas and companies. The firm provides mentorship and connects clients with experienced professionals to enhance their potential for success. As a Registered Investment Adviser, General Catalyst has managed a total of eight venture capital funds, accumulating approximately $3.75 billion in capital commitments.
Alumni Ventures Group, LLC is a venture capital firm based in Manchester, New Hampshire, founded in 2013. The firm specializes in seed and early-stage investments, as well as late-stage pre-IPO opportunities, with a flexible approach that is sector and geographic agnostic. Alumni Ventures aims to provide high-quality, diversified venture portfolios to individual investors, particularly accredited alumni from top entrepreneurial schools, who may not have had access to venture capital previously. The firm focuses on backing companies that have an alumni connection and are led by established institutional investors with expertise in their respective fields. Additionally, Alumni Ventures offers focused funds that enable accredited investors to access a diverse portfolio of investments across various types, sectors, stages, and geographies.
Perceptive Advisors LLC is an investment management firm established in 1999, with headquarters in New York City and an additional office in Boston. The firm specializes in supporting the life sciences sector, investing primarily in biotechnology, pharmaceuticals, medical devices, diagnostics, and healthcare services. Perceptive Advisors engages in venture capital and incubation, making equity investments ranging from $10 million to $200 million in both private and public companies. It manages client-focused equity portfolios and employs a long/short equity strategy as part of its hedging techniques. Additionally, the firm conducts in-house research and utilizes technical analysis to inform its investment decisions. Perceptive Advisors also provides customized debt financing solutions through its Perceptive Credit Opportunities Fund, catering to the evolving needs of healthcare companies.
Bain Capital Life Sciences Investors, LLC is a principal investment firm based in Boston, Massachusetts, focusing on investments in the life sciences sector. The firm specializes in various types of investments, including inflection capital, growth capital, buyouts, and turnaround investments. It targets biopharmaceutical, specialty pharmaceutical, medical device, diagnostics, and enabling life science technology companies worldwide. Bain Capital Life Sciences aims to support companies that drive medical innovation and address unmet medical needs, providing not only capital but also strategic assistance to enhance their growth and value during critical phases. The firm's unique expertise in the life sciences landscape allows it to effectively navigate complex investment opportunities and contribute to advancements in healthcare.
US Department of Energy is a government agency that regulates energy policy, research, and development. The Energy Department's mission is to ensure America’s security and prosperity by addressing its energy, environmental, and nuclear challenges through transformative science and technology solutions.
Founder Collective is a venture capital firm founded in 2009 and headquartered in Cambridge, Massachusetts, with an additional office in New York City. Established by a group of successful entrepreneurs, the firm aims to provide a supportive framework for early-stage technology companies. It emphasizes the importance of entrepreneurs raising the least amount of capital necessary to maintain control over their firms. The company focuses on seed-stage investments and is industry agnostic, although it shows a preference for businesses that incorporate information technology. Founder Collective seeks to guide startups through the complexities of venture capital, drawing on the firsthand experiences of its partners who have founded and sold their own technology companies.
ARCH Venture Partners, founded in 1986 and based in Chicago, Illinois, is a venture capital firm that specializes in investing in early-stage technology companies, particularly in the life sciences sector. The firm focuses on innovations that emerge from academic research institutions and national laboratories, making it a recognized leader in the commercialization of such technologies. ARCH invests conservatively in seed rounds to mitigate risk and subsequently leads or co-leads further financing rounds, aiming for a seat on the Board of Directors. Its investment strategy encompasses a wide range of sectors, including biotechnology, pharmaceuticals, advanced materials, and clean technology, among others. ARCH primarily invests in the United States while also targeting opportunities in countries like Canada, Ireland, South Korea, China, and Japan. The firm has raised over $3 billion across ten venture funds and has supported more than 150 companies in their early capital rounds.
Founded in 1986, Morningside Group is a venture capital firm based in Newton, Massachusetts. The firm seeks to invest in companies operating in the technology, internet and biotechnology sectors.
Insight Partners is a global software investor that partners with growth-stage technology and software companies. Insight has a deep focus in Fintech, Cybersecurity, AI/ML, DevOps, and Healthcare sectors. Across their people and their portfolio, they encourage a culture around a core belief growth equals opportunity. As of December 31, 2022, the firm has over $75B in regulatory assets under management. Insight Partners has invested in more than 750 companies worldwide and has seen over 55 portfolio companies achieve an IPO.
The Massachusetts Clean Energy Center (MassCEC) is a state agency established to promote the growth of the clean energy sector in Massachusetts. Founded in 2009 under the Green Jobs Act, MassCEC focuses on accelerating job creation and economic development within the clean energy industry. The organization provides early-stage investments to startups, offers renewable energy rebates for residents and businesses, and supports workforce development initiatives to prepare individuals for careers in clean energy. By leveraging the state's unique assets, MassCEC aims to facilitate the development of renewable energy projects and establish Massachusetts as a leader in the national and global clean energy landscape.
New Enterprise Associates, Inc. is a private equity and venture capital firm founded in 1977 and headquartered in Menlo Park, California, with additional offices in India and China. The firm specializes in investing across various stages of business development, from seed funding to public offerings, with a strong emphasis on the technology and healthcare sectors. Its investment strategy encompasses a wide range of industries, including information technology, consumer internet, financial technology, software, healthcare services, life sciences, biopharmaceuticals, and energy technology. New Enterprise Associates actively engages with entrepreneurs to support the growth of their companies, making investments between $0.05 million and $20 million. The firm has a global investment focus, particularly in regions such as Asia, Brazil, and the United States.
GV Investment Managers is a private equity firm founded in 2000 and based in Stamford, Connecticut. The firm specializes in impact investing, private equity, and portfolio management services. It focuses on sectors such as life sciences, consumer products, enterprise solutions, cryptocurrency, climate technology, and frontier innovations. With Alphabet as its sole limited partner, GV Investment Managers primarily targets investments in North America and Europe. The firm collaborates with operating partners who assist startups in areas such as design, diversity and inclusion, talent acquisition, and engineering, while also facilitating connections with Google for technological support and expertise.
Alexandria Venture Investments, LLC is a venture capital firm established in 1996 and located in Pasadena, California. As a subsidiary of Alexandria Real Estate Equities, the firm specializes in seed, early-stage, and growth capital investments primarily within the healthcare sector. Its focus areas include biopharma, diagnostics, life sciences, research tools, agrifood technology, and technology. By leveraging its extensive industry expertise and a robust network of relationships with leading investors and scientific advisors, Alexandria Venture Investments aims to support innovative companies that are developing breakthrough technologies and therapies to enhance human health.
SV Health Investors, established in 1993 and headquartered in Boston, Massachusetts, is a prominent venture capital and growth equity firm specializing in the healthcare and life sciences sectors. The firm manages over $2 billion across seven private healthcare funds and has a 20-year track record of investing in transformative companies and treatments in both the US and Europe. SV Health Investors focuses on a diverse array of areas, including therapeutics, biotechnology, healthcare services, dementia, and medical technology, supporting entrepreneurs who drive innovation and advancements in healthcare. With additional offices in San Francisco and London, the firm is committed to fostering breakthroughs that can significantly improve patient care and health outcomes.
Mission BioCapital is a venture capital firm based in Cambridge, Massachusetts, established in 2009. The firm specializes in investing in early-stage companies within the life sciences and biotechnology sectors. With a leadership team that has extensive experience in the industry, Mission BioCapital has a proven track record of launching and supporting numerous early-stage life science ventures. The firm operates in areas known for their significant research and development activities, which enhances its ability to identify promising investment opportunities. Portfolio company leaders recognize Mission BioCapital for its expertise and the substantial support it offers throughout the investment process.
F-Prime Capital is a venture capital firm established in 1969 and headquartered in Cambridge, Massachusetts, with additional offices in San Francisco and London. It is part of the Fidelity Investments family, which has a long history of supporting entrepreneurs. F-Prime Capital focuses its investments on companies in North America and Europe, specializing in sectors such as healthcare, life sciences, therapeutics, fashion, medtech, health information technology and services, and technology. The firm emphasizes a hands-on approach, leveraging its deep industry expertise and extensive relationships to assist entrepreneurs in building significant companies. F-Prime Capital operates without the pressures of external fundraising, allowing it to concentrate on identifying and nurturing promising ventures.
Flagship Pioneering conceives, creates, resources, and grows first-in-category ventures to transform human health and sustainability. The company accelerates Flagship Pioneering’s advances in biology, engineering, medicine, energy, and beyond. The firm harnesses science and entrepreneurialism to envision alternative futures, beginning with seemingly unreasonable propositions and navigating to transformational outcomes through an evolutionary methodology. Flagship Pioneering combines innovative capacity, entrepreneurial leadership, and professional capital management in a single enterprise that systematically produces first-in-category companies.
OrbiMed is a healthcare-focused investment firm based in New York City, established in 1989. The firm specializes in providing a range of financing solutions, including bridge loans, senior debt, and structured debt capital for both commercial-stage public and private healthcare companies. OrbiMed invests across various sectors within the healthcare industry, such as pharmaceuticals, life sciences, digital health, medical devices, biopharmaceuticals, diagnostics, healthcare technology, and biotechnology. With approximately $5 billion in assets under management, OrbiMed aims to support a spectrum of healthcare companies, from early-stage ventures to established multinational corporations.
SOSV is a global venture capital firm based in Princeton, New Jersey, founded in 1995. It specializes in early-stage investments, focusing on deep technology innovations that address human and planetary health. The firm operates startup development programs, notably HAX and IndieBio, which provide resources, facilities, and lab equipment to accelerate the growth of promising startups. SOSV supports companies from their inception through various funding stages, including seed and series A rounds, while offering ongoing assistance to help them scale and attract additional investors. By concentrating on revolutionary technologies and cross-border markets, particularly in Asia, SOSV aims to foster significant advancements that benefit humanity and the environment.
Battery Ventures is a Boston-based investment firm founded in 1983 that specializes in technology-focused investments. The firm targets category-defining businesses across various sectors, including application software, IT infrastructure, consumer internet and mobile services, industrial technologies, and life science tools. By identifying and supporting innovative companies within these markets, Battery Ventures aims to foster growth and development in the technology landscape. As a Registered Investment Adviser, the firm combines expertise and strategic insight to guide its investment decisions.
Casdin Capital is a New York-based investment firm established in 2012, specializing in fundamental research within the life sciences and healthcare sectors. The firm focuses on a range of investments, from early-stage to late-stage private opportunities, and is particularly interested in areas such as oncology, digital health, and agtech. As a Registered Investment Adviser, Casdin Capital employs a long-short equity strategy to manage its portfolio. Founded by Eli Casdin, the firm has built a reputation for its analytical approach to investing in innovative healthcare solutions, aiming to capitalize on advancements in the industry. As of October 2020, Casdin Capital managed approximately $2.2 billion in assets.
Khosla Ventures, founded in 2004 and headquartered in Menlo Park, California, is a venture capital firm that provides strategic advice, capital, and support to bold entrepreneurs across various sectors. The firm focuses on early-stage investments in areas such as artificial intelligence, climate technology, sustainability, enterprise solutions, consumer products, fintech, digital health, medical technology, and therapeutics. Khosla Ventures is particularly interested in innovative solutions that address significant socio-economic challenges and enhance productivity, especially for low-income populations and small businesses in emerging markets. The firm embraces experimentation and is open to investing in unconventional and high-risk ventures, often acting as the sole investor in groundbreaking projects. With a commitment to fostering impactful entrepreneurship, Khosla Ventures seeks to create value through technological advancements and creative business models, with a special emphasis on markets in South Asia.
Spark Capital Partners, LLC is a venture capital firm founded in 2005 with offices in San Francisco, Boston, and New York City. The firm specializes in growth capital investments, focusing on early-stage companies across a wide range of sectors, including consumer products, fintech, software, media, and e-commerce. Spark Capital is known for its unique approach to investing, emphasizing support for exceptional products and the creative individuals behind them. The firm embraces risk and aims to help founders achieve success on their own terms, often taking board seats in its portfolio companies. Spark Capital has backed notable companies such as Twitter, Discord, and Warby Parker, demonstrating its commitment to innovative ventures. With investment amounts ranging from $0.5 million to $30 million, the firm targets businesses with revenues up to $1 billion, primarily within the United States but with a global outlook.
Accel is a venture capital firm founded in 1983 and headquartered in Palo Alto, California, with additional offices in San Francisco, London, and Bangalore. The firm specializes in early and growth-stage investments, focusing on sectors such as cloud computing, software as a service (SaaS), consumer products, enterprise solutions, information technology, healthcare, fintech, security, media, and business services. Accel is dedicated to supporting a global community of entrepreneurs, identifying and backing those with the potential to drive the growth of next-generation industries. The firm's portfolio includes notable companies like Atlassian, Dropbox, and Facebook, showcasing its commitment to fostering innovation and growth in the technology landscape.
SoftBank Investment Advisers is a venture capital firm established in 2017 and headquartered in London, United Kingdom. It operates as a subsidiary of SoftBank Group Corp. and specializes in growth capital and late-stage investments predominantly within the technology sector. The firm focuses on a diverse array of industries, including internet-of-things, artificial intelligence, robotics, telecommunications, computational biology, fintech, and digital financial services. With a preference for global investments, particularly in the United States, SoftBank Investment Advisers typically commits a minimum of $100 million to both minority and majority stakes in private and public companies. The firm is known for offering operational expertise and leveraging a vast global network, aiming to support innovative companies that have the potential to revolutionize their respective fields. It maintains additional offices in key locations such as Tokyo, San Francisco, and Singapore.
Flybridge Inc. is a company based in Tokyo, Japan, founded in 2010. It specializes in providing a range of services including internet media, marketing, membership, advertising, software development, web design and development, consulting, and site reconstruction. The company focuses on supporting other businesses through its marketing and media operations, ensuring that clients can effectively engage with their audiences and enhance their online presence.
The Massachusetts Life Sciences Center (MLSC) is a quasi-public agency of the Commonwealth of Massachusetts tasked with implementing the Massachusetts Life Sciences Act, a ten-year, $1 billion initiative that was signed into law in June of 2008. The Center's mission is to create jobs in the life sciences and support vital scientific research that will improve the human condition. This work includes making financial investments in public and private institutions that are advancing life sciences research, development and commercialization as well as building ties between sectors of the Massachusetts life sciences community.
.406 Ventures, LLC is a Boston-based venture capital firm established in 2005 that specializes in early-stage investments in innovative information technology and service companies. The firm primarily focuses on sectors such as IT security and infrastructure, technology-enabled business services, and next-generation software. It seeks to partner with exceptional entrepreneurs to drive growth and create value. .406 Ventures typically invests between $2 million and $5 million initially, with total investments ranging from $6 million to $10 million per company. The firm aims to secure board representation and often takes lead roles as the first institutional investor in its portfolio companies. With an emphasis on B2B sectors, including cybersecurity, digital health, and cloud technology, .406 Ventures also allocates capital for follow-on investments and opportunistic opportunities in more mature companies experiencing significant technology and business model shifts.
Samsara BioCapital LLC is a principal investment firm established in 2016 and located in Palo Alto, California. The company specializes in providing investment advisory services aimed at supporting biotechnology firms and entrepreneurs in transforming their ideas into successful ventures. It focuses on sectors such as healthcare, life sciences, oncology, and digital health, emphasizing innovation in the development of new therapies. Samsara BioCapital actively seeks to partner with ambitious and visionary companies, fostering collaboration to advance significant advancements in biotechnology.
Schooner Capital LLC is a private investment office based in Boston, Massachusetts, that specializes in growth equity and alternative assets. Established in 1971, the firm focuses on private investments, including private equity and venture capital, across various stages and sectors. It emphasizes investments in private companies within the healthcare, technology, and clean energy sectors, primarily in the United States, while also targeting emerging and frontier markets globally. With a long-term investment approach and no outside limited partners, Schooner Capital seeks to create value through strategic investments in both private and public markets.
MassMutual Financial Group, established in 1851 and headquartered in Springfield, Massachusetts, is a mutual life insurance company that offers a comprehensive range of financial services. These include life, accident, and health insurance, as well as disability income and long-term care insurance. The company also provides annuities, college savings plans, individual retirement accounts, mutual funds, and various investment and wealth management solutions. In addition to traditional insurance products, MassMutual engages in impact investing through initiatives aimed at fostering growth in technology and sustainability-driven businesses, particularly in underserved regions. With a focus on both financial security and social impact, MassMutual serves a diverse clientele, helping them achieve their financial goals through a variety of tailored solutions.
Takeda Pharmaceutical Company Limited is a global biopharmaceutical leader that focuses on researching, developing, manufacturing, and marketing innovative medicines. The company specializes in a range of therapeutic areas, including oncology, gastroenterology, neuroscience, and rare diseases. With its commitment to improving patient outcomes, Takeda is dedicated to delivering advanced pharmaceuticals and therapeutics, as well as vaccines. Founded in 1781 and headquartered in Japan, Takeda operates worldwide, with significant research and development facilities in locations such as Cambridge, Massachusetts, and San Diego, California. The company also engages in strategic investments through its venture capital arm, which supports early-stage companies and technologies that align with its therapeutic focus, fostering collaborations that leverage its extensive R&D capabilities. Takeda's mission is to enhance the quality of life for patients globally through continuous innovation and excellence in healthcare.
The Engine, established by the Massachusetts Institute of Technology (MIT) in 2016, is a venture firm focused on supporting early-stage companies that tackle significant global challenges through innovative science and engineering. The Engine prioritizes transformative ideas over immediate profitability, offering a streamlined system that accelerates the progression from concept to market. It provides a physical workspace for startups, along with essential resources such as business planning, legal assistance, and administrative support. The Engine also connects entrepreneurs with "patient capital" from like-minded investors, allowing startups to maintain greater control over their ventures. With plans to support up to 60 startups simultaneously over a 12-month period, The Engine aims to facilitate rapid development and validation of groundbreaking concepts. Additionally, it offers access to specialized equipment and lab space through the Engine Room, fostering a collaborative environment that nurtures innovation within the MIT community and beyond.
Foresite Capital is a healthcare and life sciences investment firm founded in 2011 and based in Larkspur, California, with additional offices in San Francisco and New York. The firm adopts a data-driven and scientific approach to identify and invest in startups that leverage biology and big data to enhance healthcare outcomes. Foresite Capital focuses on multiple stages of investment in sectors such as healthcare technology, therapeutics, and life sciences. The firm collaborates closely with its portfolio companies, offering not only capital but also access to a multidisciplinary team of experts, including scientists, engineers, analysts, and clinicians. This collaborative approach aims to address significant unmet clinical needs by supporting innovative healthcare solutions across various stages of development. Foresite Capital manages $2 billion in assets and emphasizes investments in companies utilizing data science and machine intelligence to advance healthcare.
Hyperplane Venture Capital is an investment firm focused on exceptional founders building machine intelligence and data companies. They partner with exceptional founders who are leveraging machine intelligence, sensor technology, and cloud computing to solve the world’s hardest problems uncovering the underlying structure for each problem and creating solutions at the nexus of perception, communication, intelligence, and insight. The company was founded by Vivjan Myrto, John Murphy and Brendan Kohler in 2015; and is headquartered in Boston, Massachusetts.
Bristol-Myers Squibb Company is a global biopharmaceutical firm engaged in the discovery, development, licensing, manufacturing, and marketing of pharmaceutical products. The company specializes in therapeutics across several key areas, including hematology, oncology, cardiovascular health, and immunology. Notable products include Opdivo for cancer treatment, Eliquis for stroke prevention and venous thromboembolic disorders, and Orencia for rheumatoid arthritis. Additionally, Bristol-Myers Squibb offers therapies for chronic hepatitis B and HIV, among others. The company has significant collaborations with various partners in the pharmaceutical industry, including major players like Pfizer and AstraZeneca. Founded in 1887 and headquartered in New York City, Bristol-Myers Squibb has a strong presence in the U.S. market, which accounts for approximately 70% of its total sales.
Invus Financial Advisors, LLC is an employee-owned investment firm based in New York, founded in 2006. The firm specializes in private equity investments and manages pooled investment vehicles, including hedge funds and funds of funds. Invus focuses on making direct and indirect investments in special situations, venture capital, and growth equity stages, with an emphasis on smaller companies and opportunistic co-investments. The firm adopts a flexible approach, recognizing the uniqueness of each company and the complexities of business transformation. Invus maintains a long-term commitment to its investments, aligning its incentives with those of its partners. With a history of empowering owner-managers since 1985 and a strong backing from a group of European families, Invus Financial Advisors manages over $4 billion in an evergreen fund and operates additional offices in London, Paris, and Hong Kong.
Matrix Partners is a venture capital firm founded in 1977 and based in San Francisco, California. The firm specializes in early-stage investments, supporting companies from the ideation phase through Series A funding. Matrix Partners focuses on various sectors, including applied artificial intelligence, B2B SaaS, digital health, fintech, and sustainable hardware. The firm prides itself on building long-term relationships with entrepreneurs, leveraging a team of former founders and experienced investors to foster significant, industry-leading companies. With a strong portfolio that includes notable investments like Oculus, Zendesk, and Afterpay, Matrix Partners has contributed to the success of numerous businesses, helping many achieve initial public offerings and profitable mergers and acquisitions. The firm combines local market knowledge with a global perspective, consistently ranking among the top venture firms in terms of returns to its investors.
T. Rowe Price Group is an investment management and financing advisory firm based in Baltimore, Maryland, founded in 1937. The company offers a comprehensive range of investment strategies, including debt, equities, and private equity, catering to a diverse clientele that includes individuals, high-net-worth individuals, financial institutions, retirement plan sponsors, charitable organizations, corporations, and government entities. T. Rowe Price provides services such as separate account management, mutual funds, and sub-advisory services, positioning itself as a trusted partner in managing and growing investments across various sectors. The firm is also involved in funding technology startups, reflecting its commitment to innovation and adapting to emerging market trends.
Northpond Ventures is a science-driven venture capital firm headquartered in Bethesda, Maryland. Our mission is to build a better tomorrow. Our investments are focused on life sciences, technology, and affiliated industries.
Deerfield Management is a New York-based healthcare company founded in 1994 that operates across investment, information, and philanthropy. As a registered investment adviser, it focuses on providing a robust healthcare ecosystem through various investment strategies. The firm engages in both private and public investments, targeting companies within the life sciences, medical device, diagnostic, digital health, and health services sectors. Deerfield's commitment extends beyond financial support, as it also emphasizes the importance of information and philanthropy in enhancing healthcare outcomes.
Highland Capital Partners is a venture capital firm founded in 1988, with offices in Boston, Silicon Valley, and Shanghai. The firm is dedicated to supporting entrepreneurs and has raised over $3 billion in committed capital, investing in more than 225 companies. Its focus spans both consumer and enterprise technology sectors, leading to the development of category-defining businesses. Notable investments include companies such as 2U, Ask Jeeves, and Rent the Runway. In addition to its investment activities, Highland Capital Partners fosters the next generation of entrepreneurs through initiatives like Summer@Highland, which provides mentorship and resources for students and university-affiliated startups.